Suppr超能文献

通过食蟹猴局部给药提高腺相关病毒介导的肝脏转导效率

Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis.

作者信息

Zabaleta Nerea, Salas David, Paramo Maria, Hommel Mirja, Sier-Ferreira Valerie, Hernandez-Alcoceba Ruben, Prieto Jesus, Bilbao Jose I, Gonzalez-Aseguinolaza Gloria

机构信息

1 Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research, Health Research Institute of Navarra (IdisNA) , Pamplona, Spain .

2 Radiology Department, Clínica Universidad de Navarra, IdisNA, Pamplona, Spain .

出版信息

Hum Gene Ther Clin Dev. 2017 Jun;28(2):68-73. doi: 10.1089/humc.2016.183. Epub 2017 Mar 10.

Abstract

The liver is a central organ in metabolism and can be affected by numerous inherited metabolic disorders. Recombinant adeno-associated virus (AAV)-based gene therapy represents a promising therapeutic approach for such diseases. AAVs have been demonstrated to be safe, and resulted in high and long-term expression in preclinical and clinical studies. However, there are still some concerns regarding the expression levels that can be achieved and the percentage of hepatocytes that can be transduced. Because of the cell-autonomous nature of most metabolic liver disorders, a high percentage of hepatocytes needs to be corrected in order to achieve a therapeutic effect. The goal of our work was to improve transduction efficacy of the liver by conveying the vector directly to hepatic tissue. Interventional radiology procedures were used to administer an AAV5 vector expressing a secreted form of human embryonic alkaline phosphatase (hSEAP) under the control of a liver-specific promoter to a clinically relevant animal model, Macaca fascicularis. Balloon occlusion of the regional hepatic venous flow was performed while injecting the vector either into the hepatic artery (HA) or, against flow, via the suprahepatic vein (SHV). In both cases the vector was injected into the right hepatic lobules, and the two routes were compared with conventional intravenous administration. Higher hSEAP levels were obtained when the vector was administered via SHV or HA than after intravenous injection. Furthermore, higher expression levels correlated with a higher number of vector genomes in the injected lobules. In conclusion, direct administration of AAV vectors via the hepatic blood flow with simultaneous balloon occlusion of the hepatic outflow increases liver transduction efficacy in comparison with systemic delivery and can be further improved in bigger animals or humans, where it would be technically feasible to inject the vector into the hepatic vasculature in the generality of lobules.

摘要

肝脏是新陈代谢的中心器官,会受到多种遗传性代谢紊乱的影响。基于重组腺相关病毒(AAV)的基因疗法是治疗此类疾病的一种有前景的治疗方法。在临床前和临床研究中,AAV已被证明是安全的,并能实现高效且长期的表达。然而,对于能够达到的表达水平以及可被转导的肝细胞百分比仍存在一些担忧。由于大多数代谢性肝脏疾病具有细胞自主性,需要校正高比例的肝细胞才能达到治疗效果。我们工作的目标是通过将载体直接输送到肝组织来提高肝脏的转导效率。采用介入放射学方法,将在肝脏特异性启动子控制下表达分泌型人胚胎碱性磷酸酶(hSEAP)的AAV5载体给予临床相关动物模型食蟹猴。在将载体注入肝动脉(HA)或逆血流经肝上静脉(SHV)时,进行区域性肝静脉血流球囊闭塞。在这两种情况下,载体均注入右肝小叶,并将这两种途径与传统静脉给药进行比较。与静脉注射后相比,通过SHV或HA给药时获得的hSEAP水平更高。此外,更高的表达水平与注射小叶中更高数量的载体基因组相关。总之,与全身给药相比,通过肝血流直接给药并同时球囊闭塞肝流出道可提高肝脏转导效率,并且在更大的动物或人类中可进一步改善,在这些动物或人类中,将载体注入大多数小叶的肝血管系统在技术上是可行的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验